Sort by
Refine Your Search
-
Employer
- Centre for Genomic Regulation
- Institut d'Investigació Biomèdica Sant Pau
- Institute for bioengineering of Catalonia, IBEC
- Institute of Photonic Sciences
- CIC bioGUNE
- FUNDACIÓ ESADE - UNIVERSITAT RAMON LLULL
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- ICN2
- Institute of Chemical Research of Catalonia ICIQ
- Universitat de Barcelona
-
Field
-
English. Advanced proficiency in office software tools (Excel, Word, PowerPoint, etc.). Desirable qualifications Experience in preclinical models of therapies targeting human cells, tumour cells
-
. Researchers in the group also participate in several clinical trials involving gene therapy and drug repurposing, and investigate DNA repair genes involved in these syndromes as therapeutic targets against
-
is commensurate with qualifications and consistent with our pay scales · Target start date: September 2026 We provide a highly stimulating environment with state-of-the-art infrastructures, and
-
bioGUNE (Bilbao-Spain), led by Dr. Ana Ruiz-Saenz, strive to understand the molecular mechanisms underlying resistance to targeting therapies. Current and future projects are exploring new aspects
-
of the nanobots and their ability to navigate viscous biological barriers (such as synovial fluid). In vitro and in vivo studies on the efficacy of the developed nanobots for targeted delivery and tissue
-
the subject matter of the email. Deadline for applications is August 24, 2026. The target starting date for the position is October 1, 2026. Work Location(s) Number of offers available1Company
-
: Project Leadership & Design: Drive the experimental design, optimization, and advanced surface functionalization of organic-based nanoparticles to serve as active, targeted therapeutic carriers. Advanced
-
· Strong experimental intuition and problem-solving mindset in synthesis-driven research. · High level of motivation, curiosity, and resilience when facing challenging synthetic targets · Excellent
-
neurobiology, the candidate will: Engineer new channelrhodopsin variants incorporating secondary light-absorbing groups. Design and execute in vitro reconstitution experiments with purified proteins and targeted
-
remediation strategies in pilot‑scale field tests targeting nutrients, VOCs and CECs. The selected postdoctoral researcher will support the development, optimisation and application of analytical and isotopic